Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | MEN1 | O00255 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
| ▸ | DPP4 | P27487 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9891022 | 1.00 | ALDH1A1 (0.36) | ALDH1A1KMT2AMEN1POLBDPP4 | |
| SCHEMBL19680274 | 0.74 | DPP4 (0.34) | ALDH1A1KMT2AMEN1POLBDPP4 | |
| SCHEMBL18708643 | 0.72 | HTR2C (0.33) | ALDH1A1KMT2AMEN1POLBDPP4 | |
| SCHEMBL17952359 | 0.71 | ALDH1A1 (0.33) | ALDH1A1KMT2AMEN1POLB | |
| SCHEMBL13875989 | 0.69 | ALDH1A1 (0.37) | ALDH1A1KMT2AMEN1POLBMAPT | |
| SCHEMBL20627486 | 0.69 | ALDH1A1 (0.31) | ALDH1A1DPP4 | |
| SCHEMBL13969349 | 0.67 | NISCH (0.34) | ALDH1A1KMT2AMEN1POLB | |
| SCHEMBL17952209 | 0.67 | CYP1A2 (0.33) | ALDH1A1KMT2AMEN1POLB | |
| SCHEMBL13875971 | 0.66 | HTR2C (0.35) | — | |
| SCHEMBL11921038 | 0.65 | MEN1 (0.34) | ALDH1A1KMT2AMEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11818948-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2023-11-14 | — | — | US | disclosed |
| US-11692131-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes | UDC IRELAND LIMITED (IE) | 2023-07-04 | — | — | US | disclosed |
| US-11692131-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes | UDC IRELAND LIMITED (IE) | 2023-07-04 | — | — | US | disclosed |
| US-20200119288-A1 | Metal-Assisted Delayed Fluorescent Emitters Employing Benzo-imidazo-phenanthridine and Analogues | UNITED STATES DEPARTMENT OF ENERGY | 2020-04-16 | — | — | US | disclosed |
| US-20190322929-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES | UDC IRELAND LTD (IE) | 2019-10-24 | — | — | US | disclosed |
| US-9306179-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-04-05 | — | — | US | disclosed |
| US-9306179-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2016-04-05 | — | — | US | disclosed |
| US-8877937-B2 | Process for preparing transition metal-carbene complexes | BASF SE (DE) | 2014-11-04 | — | — | US | disclosed |
| US-8877937-B2 | Process for preparing transition metal-carbene complexes | BASF SE (DE) | 2014-11-04 | — | — | US | disclosed |
| US-8728632-B2 | Metal complexes comprising bridged carbene ligands and use thereof in OLEDs | BASF SE (DE) | 2014-05-20 | — | — | US | disclosed |
| US-8383828-B2 | Transition metal complexes comprising one noncarbene ligand and one or two carbene ligands and their use in OLEDs | BASF AKTIENGESELLSCHAFT (DE) | 2013-02-26 | — | — | US | disclosed |
| US-8258297-B2 | Transition metal complexes with bridged carbene ligands and use thereof in OLEDs | BASF SE (DE) | 2012-09-04 | — | — | US | disclosed |
| EP-2338593-A1 | Process for the preparation of transition metal carbene complexes | BASF SE (DE) | 2011-06-29 | — | — | EP | disclosed |
| US-20100264405-A1 | TRANSITION METAL COMPLEXES WITH BRIDGED CARBENE LIGANDS AND USE THEREOF IN OLEDS | BASF SE (DE) | 2010-10-21 | — | — | US | disclosed |
| US-20100213834-A1 | TRANSITION METAL COMPLEXES COMPRISING BRIDGED CARBENE LIGANDS AND USE THEREOF IN OLEDS | BASF SE (DE) | 2010-08-26 | — | — | US | disclosed |
| US-20090096367-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) | BASF SE (DE) | 2009-04-16 | — | — | US | disclosed |
| US-20090054657-A1 | Transition Metal Complexes Comprising One Noncarbene Ligand and One or Two Carbene Ligands and their Use in Oleds | BASF SE (DE) | 2009-02-26 | — | — | US | disclosed |
| US-20090018330-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | BASF SE (DE) | 2009-01-15 | — | — | US | disclosed |
| US-20090018330-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | BASF SE (DE) | 2009-01-15 | — | — | US | disclosed |
| WO-2007088093-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | BASF SE (DE) | 2007-08-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090018330-A1 | PROCESS FOR PREPARING TRANSITION METAL-CARBENE COMPLEXES | AP1M1, C1S, GPS1 | ALDH1A1 2893/4885KMT2A 2456/4885MEN1 51/4885 |
| US-20090096367-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES (OLEDS) | OCIAD2, OCIAD1, ICOSLG | ALDH1A1 1119/4885KMT2A 3028/4885MEN1 3745/4885 |
| US-20190322929-A1 | HETEROLEPTIC TRANSITION METAL-CARBENE COMPLEXES AND THEIR USE IN ORGANIC LIGHT-EMITTING DIODES | CLTB, CLTC, CYBA | ALDH1A1 1498/4885KMT2A 2033/4885MEN1 2607/4885 |
| US-20090054657-A1 | Transition Metal Complexes Comprising One Noncarbene Ligand and One or Two Carbene Ligands and their Use in Oleds | OCIAD1, OCIAD2, ICOSLG | ALDH1A1 1163/4885KMT2A 3313/4885MEN1 3677/4885 |
| US-11818948-B2 | Organic electroluminescent materials and devices | SLCO4C1, SLC29A1, SLC29A2 | ALDH1A1 1044/4885KMT2A 1491/4885MEN1 1698/4885 |
| US-20200119288-A1 | Metal-Assisted Delayed Fluorescent Emitters Employing Benzo-imidazo-phenanthridine and Analogues | IK, HELZ, SUN2 | ALDH1A1 1492/4885KMT2A 453/4885MEN1 3029/4885 |
| US-11692131-B2 | Heteroleptic transition metal-carbene complexes and their use in organic light-emitting diodes | CLTB, CLTC, CYBA | ALDH1A1 1498/4885KMT2A 2033/4885MEN1 2607/4885 |
| US-20100213834-A1 | TRANSITION METAL COMPLEXES COMPRISING BRIDGED CARBENE LIGANDS AND USE THEREOF IN OLEDS | OCIAD1, OCIAD2, OPRD1 | ALDH1A1 696/4885KMT2A 3450/4885MEN1 4325/4885 |
| US-20100264405-A1 | TRANSITION METAL COMPLEXES WITH BRIDGED CARBENE LIGANDS AND USE THEREOF IN OLEDS | OCIAD1, OCIAD2, OPRD1 | ALDH1A1 656/4885KMT2A 3439/4885MEN1 4209/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.